FDA - A Risk-Based Approach to Monitoring of Clinical Investigations Questions and Answers

26th April 2023

FDA

A Risk-Based Approach to Monitoring of Clinical Investigations Questions and Answers.

This guidance provides information on risk-based approaches to monitoring the conduct of clinical investigations of human drug and biological products, medical devices, and combination products.

Read More

Back to News Archive